International Society on Thrombosis and Haemostasis Launches Editor(s)-in-Chief Search for Its Flagship Journal
Call for Applications Now Open for Succeeding Editor(s)-in-Chief of the Journal of Thrombosis and Haemostasis
Chapel Hill, NC, January 19, 2017 --(PR.com)-- The International Society on Thrombosis and Haemostasis (ISTH) is seeking candidates for the Editor(s)-in-Chief position for its flagship scientific journal, the Journal of Thrombosis and Haemostasis (JTH).
JTH is internationally regarded as the leading and most prestigious scientific journal in the field of thrombosis, hemostasis, and vascular biology. With an Impact Factor of 5.565 and an acceptance rate of 29 percent, JTH is a highly competitive scientific journal.
“Through the diffusion and exchange of information and ideas within the international research community, JTH strives to advance science and provide the most cutting-edge leadership and research,” said Ingrid Pabinger, ISTH Chairman of Council. “This position represents a remarkable opportunity for candidates at the peak of their careers to shape the future of the field and lead JTH to even greater heights.”
This exciting editorial opportunity consists of a 4-year term commencing January 1, 2019, with the possibility of a 2-year term extension. Open to an individual or a team of two, the Editors(s)-in-Chief will be expected to assemble a high-performing editorial team and continue to spearhead the vision and direction of the journal in collaboration with the goals and mission of the ISTH.
Following the notable leadership of current JTH Editors-in-Chief Frits Rosendaal and Pieter Reitsma, the ideal candidate(s) should be (a) scientifically recognized physician(s)/scientist(s) in the thrombosis and hemostasis field with robust leadership and editorial skills, as well as strong international connections. Interested candidates must have the ability to make the necessary time commitment required for this position.
Among a variety of benefits, the Editor(s)-in-Chief will be eligible for a competitive editorial stipend, travel support, and the expertise and prestige of working with Wiley as publisher of the journal. Editorial management will also be provided.
“The ISTH is committed to the evolution of JTH,” Pabinger said. “We are looking for an individual or individuals who - together with their editorial team - can provide the necessary vision, leadership, energy, and scientific gravitas to further develop and amplify the success of JTH, as well as the Society.”
For more information and to apply, visit www.isth.org/jthsearch. Applications are due no later than April 7, 2017. The new Editor(s)-in-Chief are expected to be announced by the end of 2017. To learn more about the ISTH, visit www.isth.org.
About the ISTH
Founded in 1969, the ISTH is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. ISTH is an international professional membership organization with more than 4,000 clinicians, researchers and educators working together to improve the lives of patients in more than 94 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs, research activities, meetings and congresses, peer-reviewed publications, expert committees and World Thrombosis Day on 13 October. Visit ISTH online at www.isth.org/.
Media Contact
Louise Bannon, Director of Marketing + Membership
International Society on Thrombosis and Haemostasis
+1 919-929-3807
Louise_Bannon@isth.org
JTH is internationally regarded as the leading and most prestigious scientific journal in the field of thrombosis, hemostasis, and vascular biology. With an Impact Factor of 5.565 and an acceptance rate of 29 percent, JTH is a highly competitive scientific journal.
“Through the diffusion and exchange of information and ideas within the international research community, JTH strives to advance science and provide the most cutting-edge leadership and research,” said Ingrid Pabinger, ISTH Chairman of Council. “This position represents a remarkable opportunity for candidates at the peak of their careers to shape the future of the field and lead JTH to even greater heights.”
This exciting editorial opportunity consists of a 4-year term commencing January 1, 2019, with the possibility of a 2-year term extension. Open to an individual or a team of two, the Editors(s)-in-Chief will be expected to assemble a high-performing editorial team and continue to spearhead the vision and direction of the journal in collaboration with the goals and mission of the ISTH.
Following the notable leadership of current JTH Editors-in-Chief Frits Rosendaal and Pieter Reitsma, the ideal candidate(s) should be (a) scientifically recognized physician(s)/scientist(s) in the thrombosis and hemostasis field with robust leadership and editorial skills, as well as strong international connections. Interested candidates must have the ability to make the necessary time commitment required for this position.
Among a variety of benefits, the Editor(s)-in-Chief will be eligible for a competitive editorial stipend, travel support, and the expertise and prestige of working with Wiley as publisher of the journal. Editorial management will also be provided.
“The ISTH is committed to the evolution of JTH,” Pabinger said. “We are looking for an individual or individuals who - together with their editorial team - can provide the necessary vision, leadership, energy, and scientific gravitas to further develop and amplify the success of JTH, as well as the Society.”
For more information and to apply, visit www.isth.org/jthsearch. Applications are due no later than April 7, 2017. The new Editor(s)-in-Chief are expected to be announced by the end of 2017. To learn more about the ISTH, visit www.isth.org.
About the ISTH
Founded in 1969, the ISTH is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. ISTH is an international professional membership organization with more than 4,000 clinicians, researchers and educators working together to improve the lives of patients in more than 94 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs, research activities, meetings and congresses, peer-reviewed publications, expert committees and World Thrombosis Day on 13 October. Visit ISTH online at www.isth.org/.
Media Contact
Louise Bannon, Director of Marketing + Membership
International Society on Thrombosis and Haemostasis
+1 919-929-3807
Louise_Bannon@isth.org
Contact
International Society on Thrombosis and Haemostasis (ISTH)
Louise Bannon, Director of Marketing + Membership
1-919-929-3807
www.isth.org
Louise Bannon, Director of Marketing + Membership
1-919-929-3807
www.isth.org
Contact
Categories